ISIN | CH0595227429 |
---|---|
Valor Number | 59522742 |
Bloomberg Global ID | VRFSVEC SW |
Fund Name | Raiffeisen Futura - Swiss Stock VE |
Fund Provider |
Raiffeisen Schweiz Genossenschaft, St. Gallen
St. Gallen, Switzerland Phone: +41 71 225 98 78 E-Mail: fonds@raiffeisen.ch Web: www.raiffeisen.ch |
Fund Provider | Raiffeisen Schweiz Genossenschaft, St. Gallen |
Representative in Switzerland |
Raiffeisen Schweiz Genossenschaft St. Gallen Phone: +41 71 225 98 78 |
Distributor(s) |
Raiffeisen Schweiz Genossenschaft St. Gallen Phone: +41 71 225 98 78 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 119.43 CHF | 10.03.2025 |
---|---|---|
Previous Price * | 120.18 CHF | 07.03.2025 |
52 Week High * | 120.53 CHF | 13.02.2025 |
52 Week Low * | 105.19 CHF | 17.04.2024 |
NAV * | 119.43 CHF | 10.03.2025 |
Issue Price * | 119.43 CHF | 10.03.2025 |
Redemption Price * | 119.43 CHF | 10.03.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 2,299,671,508 | |
Unit/Share Assets *** | 537,301,296 | |
Trading Information SIX |
YTD Performance | +8.55% |
31.12.2024 - 10.03.2025
31.12.2024 10.03.2025 |
---|---|---|
1 month | +0.54% |
10.02.2025 - 10.03.2025
10.02.2025 10.03.2025 |
3 months | +7.73% |
10.12.2024 - 10.03.2025
10.12.2024 10.03.2025 |
6 months | +5.17% |
10.09.2024 - 10.03.2025
10.09.2024 10.03.2025 |
1 year | +11.41% |
11.03.2024 - 10.03.2025
11.03.2024 10.03.2025 |
2 years | +20.58% |
10.03.2023 - 10.03.2025
10.03.2023 10.03.2025 |
3 years | +16.25% |
10.03.2022 - 10.03.2025
10.03.2022 10.03.2025 |
5 years | +23.20% |
25.02.2021 - 10.03.2025
25.02.2021 10.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 13.72% | |
---|---|---|
Novartis AG Registered Shares | 12.44% | |
ABB Ltd | 5.61% | |
Zurich Insurance Group AG | 4.80% | |
Swiss Re AG | 3.87% | |
Sika AG | 3.87% | |
Lonza Group Ltd | 3.18% | |
Alcon Inc | 3.13% | |
Partners Group Holding AG | 2.89% | |
Holcim Ltd | 2.87% | |
Last data update | 30.11.2024 |
TER | 0.30% |
---|---|
TER date | 31.07.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.40% |
Ongoing Charges *** | 0.31% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |
GMOs |